BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 33542252)

  • 1. Sensitive mass spectrometric determination of kinin-kallikrein system peptides in light of COVID-19.
    Gangnus T; Burckhardt BB
    Sci Rep; 2021 Feb; 11(1):3061. PubMed ID: 33542252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted LC-MS/MS platform for the comprehensive determination of peptides in the kallikrein-kinin system.
    Gangnus T; Burckhardt BB
    Anal Bioanal Chem; 2021 May; 413(11):2971-2984. PubMed ID: 33693976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometric study of variation in kinin peptide profiles in nasal fluids and plasma of adult healthy individuals.
    Gangnus T; Bartel A; Burckhardt BB
    J Transl Med; 2022 Mar; 20(1):146. PubMed ID: 35351153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards understanding the kallikrein-kinin system: insights from measurement of kinin peptides.
    Campbell DJ
    Braz J Med Biol Res; 2000 Jun; 33(6):665-77. PubMed ID: 10829095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of the kallikrein-kinin system in bronchoalveolar lavage fluid of patients with severe COVID-19.
    Martens CP; Van Mol P; Wauters J; Wauters E; Gangnus T; Noppen B; Callewaert H; Feyen JHM; Liesenborghs L; Heylen E; Jansen S; Pereira LCV; Kraisin S; Guler I; Engelen MM; Ockerman A; Van Herck A; Vos R; Vandenbriele C; Meersseman P; Hermans G; Wilmer A; Martinod K; Burckhardt BB; Vanhove M; Jacquemin M; Verhamme P; Neyts J; Vanassche T
    EBioMedicine; 2022 Sep; 83():104195. PubMed ID: 35939907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kallikrein-kinin system in humans.
    Campbell DJ
    Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1060-5. PubMed ID: 11903316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The renin-angiotensin and the kallikrein-kinin systems.
    Campbell DJ
    Int J Biochem Cell Biol; 2003 Jun; 35(6):784-91. PubMed ID: 12676165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
    van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
    Elife; 2020 Apr; 9():. PubMed ID: 32338605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The des-Arg
    Mendes GMM; Do Nascimento IJB; Marazzi-Diniz PH; Da Silveira IB; Itaborahy MF; Viana LE; Silva FA; Santana MF; Pinto RA; Dutra BG; Lacerda MVG; Araujo SA; Wanderley D; Vidigal PV; Diniz PH; Verano-Braga T; Santos RA; Leite MF
    Front Physiol; 2022; 13():1080837. PubMed ID: 36601349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis for kinin selectivity and activation of the human bradykinin receptors.
    Yin YL; Ye C; Zhou F; Wang J; Yang D; Yin W; Wang MW; Xu HE; Jiang Y
    Nat Struct Mol Biol; 2021 Sep; 28(9):755-761. PubMed ID: 34518695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-salt diet downregulates plasma but not tissue kallikrein-kinin system.
    Hilgenfeldt U; Puschner T; Riester U; Finsterle J; Hilgenfeldt J; Ritz E
    Am J Physiol; 1998 Jul; 275(1):F88-93. PubMed ID: 9689009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The plasma and tissue kininogen-kallikrein-kinin system: role in the cardiovascular system.
    Marcondes S; Antunes E
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Jan; 3(1):33-44. PubMed ID: 15638742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key?
    Meini S; Zanichelli A; Sbrojavacca R; Iuri F; Roberts AT; Suffritti C; Tascini C
    Front Immunol; 2020; 11():2014. PubMed ID: 32849666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The kinin system: suggestions to broaden some prevailing concepts.
    Erdös EG; Deddish PA
    Int Immunopharmacol; 2002 Dec; 2(13-14):1741-6. PubMed ID: 12489787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibition modifies angiotensin but not kinin peptide levels in human atrial tissue.
    Campbell DJ; Duncan AM; Kladis A
    Hypertension; 1999 Aug; 34(2):171-5. PubMed ID: 10454436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinins in humans.
    Duncan AM; Kladis A; Jennings GL; Dart AM; Esler M; Campbell DJ
    Am J Physiol Regul Integr Comp Physiol; 2000 Apr; 278(4):R897-904. PubMed ID: 10749777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinin-related effects of angiotensin-converting enzyme inhibition.
    Bönner G
    Clin Physiol Biochem; 1990; 8 Suppl 1():6-15. PubMed ID: 2257722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The kallikrein-kinin system: current and future pharmacological targets.
    Moreau ME; Garbacki N; Molinaro G; Brown NJ; Marceau F; Adam A
    J Pharmacol Sci; 2005 Sep; 99(1):6-38. PubMed ID: 16177542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinins are involved in the development of allergic nasal hyperresponsiveness in guinea pigs.
    Sugahara S; Nabe T; Mizutani N; Takenaka H; Kohno S
    Eur J Pharmacol; 2003 Aug; 476(3):229-37. PubMed ID: 12969770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible protective effects of kinins and converting enzyme inhibitors in cardiovascular tissues.
    Nolly H; Miatello R; Damiani MT; Abate CD
    Immunopharmacology; 1997 Jun; 36(2-3):185-91. PubMed ID: 9228545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.